REFERENCES

  1. Light RW. Pleural Diseases. 3rd rev, ed. Baltimore, Md: Williams & Wilkins, 1995:52-3.
  2. Fenton KN, Richardson JD. Diagnosis and management of pleural effusions. Am J Surg 1995; 170:69-74.
  3. Jarvi OH, Kunnas RJ, Laitio MT, Tyrkko JES. The accuracy and significance of cytologic cancer diagnosis of pleural effusions. Acta Cytol 1972; 16:152-7.
  4. Grunze H. The comparative diagnostic accuracy, efficiency and specificity of cytologic techniques used in the diagnosis of malignant neoplasm in serous effusions of the pleural and pericardial cavities. Acta Cytol 1964; 8:150-64.
  5. Dekker A, Bupp PA. Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 1978; 70:855-60.
  6. Prakash URS, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60:158-64.
  7. Bueno CE, Clemente G, Castro BC, Martin LM, Ramos, Panzio AG, et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Arch Intern Med 1990; 150:1190-4.
  8. Schwartz ML, Sessler CN. When-and-how to perform percutaneous pleural biopsy. J Respir Dis 1991; 12:1155-69.
  9. Light RW, MacGregor MI, Luchsinger PC, Ball WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507-13.
  10. Spriggs AI, Boddington MM. The cytology of effusions. 2nd rev. ed. New York: Grune and Stratton, 1968:12-4.
  11. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974; 33:916-22.
  12. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977; 63:695-702.
  13. Maher GG, Berger HW. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis 1972; 105:458-60.
  14. Light RW, Erozan YS, Ball WC. Cells in pleural fluid: their value in differential diagnosis. Arch Intern Med 1973; 132:854-60.
  15. Naylor B, Schmidt RW. The case for exfoliative cytology of serous effusions. Lancet 1964; 1:711-2.
  16. Starr RL, Sherman ME. The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis. Acta Cytol 1991; 35:533-7.
  17. Jonasson JG, BS Ducatman, HH Wang. The cell block for body cavity fluids: do the results justify the cost? Mod Pathol 1990; 3:667-70.
  18. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975; 67:536-9.
  19. Melamed MR. The cytological presentation of malignant lymphomas and related diseases in effusions. Cancer 1963; 16:413-31.
  20. Scerbo J, Keltz H, Stone DJ. A prospective study of closed pleural biopsies. JAMA 1971; 218:377-80.
  21. Mestitz P, Purves MJ, Pollard AC. Pleural biopsy in the diagnosis of pleural effusion. Lancet 1958; 2:1349-53.
  22. Von Hoff DD, LiVolsi V. Diagnostic reliability of needle biopsy of the parietal pleura. Am J Clin Pathol 1975; 64: 200-3.
  23. Levine H, Cugell DW. Blunt-end needle biopsy of pleura and rib. Arch Intern Med 1971; 109:516-25.
  24. Frist B, Kahan AV, Koss LG. Comparison of the diagnostic values of the biopsies of the pleura and cytologic evaluation of pleural fluids. Am J Clin Pathol 1979; 72:48-51.
  25. Canto A, Rivas J, Saumench J, et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84:176-9.
  26. Mathay RA, Coppage L, Shaw C, Filderman AE. Malignancies metastatic to the pleura. Invest Radiol 1990; 25:601-19.
  27. Wirth PR, Legier J, Wright JL Jr. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adencarcinoma. Cancer 1991; 67:655-62.
  28. Frisman DM, McCarthy WF, Schleiff P, Buckner SB. Nocito JD Jr, O’Leary TJ. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Modern Path 1993; 6:179-84.
  29. Brown RW, Clark JM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Human Path 1993; 24:347-54.
  30. Garcia-Pachon E, Padilla-Navas Isabel, Dosda D, Miralles-Llopis A. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions. Chest 1997; 111:643-47.
  31. Marel M, Staastny B, Melinova L, Svandova E, Light RW. Diagnosis of pleural effusions. Experience with clinical studies, 1986-1990. Chest 1995; 107:1598-603.
  32. Moriarty AT, Wiersema L, Snyder W, Kotylo PK, McCloskey DW. Immunophenotyping of cytologic specimens by flow cytometry. Diag Cytopath 1993; 9:252-8.
    33.